HK1249098A1 - 用於生產氟美他酚的方法 - Google Patents
用於生產氟美他酚的方法Info
- Publication number
- HK1249098A1 HK1249098A1 HK18108745.1A HK18108745A HK1249098A1 HK 1249098 A1 HK1249098 A1 HK 1249098A1 HK 18108745 A HK18108745 A HK 18108745A HK 1249098 A1 HK1249098 A1 HK 1249098A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- flutemetamol
- producing
- producing flutemetamol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Ink Jet (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015211413A JP6485914B2 (ja) | 2015-10-28 | 2015-10-28 | フルテメタモルの製造方法 |
PCT/EP2016/074840 WO2017071980A1 (en) | 2015-10-28 | 2016-10-17 | Method for producing flutemetamol |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1249098A1 true HK1249098A1 (zh) | 2018-10-26 |
Family
ID=57144967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18108745.1A HK1249098A1 (zh) | 2015-10-28 | 2018-07-06 | 用於生產氟美他酚的方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US10472338B2 (zh) |
EP (1) | EP3368518B1 (zh) |
JP (1) | JP6485914B2 (zh) |
CN (1) | CN108137520B (zh) |
AU (1) | AU2016344537B2 (zh) |
CA (1) | CA2998985C (zh) |
ES (1) | ES2766474T3 (zh) |
HK (1) | HK1249098A1 (zh) |
IL (1) | IL258148B (zh) |
MX (1) | MX2018005046A (zh) |
RU (1) | RU2733398C2 (zh) |
WO (1) | WO2017071980A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6485914B2 (ja) | 2015-10-28 | 2019-03-20 | 日本メジフィジックス株式会社 | フルテメタモルの製造方法 |
JP6770837B2 (ja) * | 2016-06-28 | 2020-10-21 | 日本メジフィジックス株式会社 | 放射性フッ素標識有機化合物を製造する方法 |
KR20200016863A (ko) * | 2017-06-23 | 2020-02-17 | 니혼 메디피직스 가부시키가이샤 | 방사성 할로겐 표지 화합물의 제조 방법 및 방사성 의약의 제조 방법 |
GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1010280A3 (fr) * | 1996-05-02 | 1998-05-05 | Coincidence S A | Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose. |
GB0229686D0 (en) * | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
WO2006133732A1 (en) * | 2005-06-17 | 2006-12-21 | Advanced Accelerator Applications | Process for synthesizing labelled compounds |
GB0516564D0 (en) * | 2005-08-12 | 2005-09-21 | Ge Healthcare Ltd | Fluorination process |
KR101317258B1 (ko) * | 2006-05-11 | 2013-10-14 | 니혼 메디피직스 가부시키가이샤 | 방사성 불소 표식 유기 화합물의 제조 방법 |
PL2182988T3 (pl) * | 2007-08-30 | 2015-02-27 | Ge Healthcare Ltd | Kompozycja radiofarmaceutyczna |
PT2509637T (pt) * | 2009-10-08 | 2016-10-05 | Ge Healthcare Ltd | Processo de purificação |
JP6485914B2 (ja) | 2015-10-28 | 2019-03-20 | 日本メジフィジックス株式会社 | フルテメタモルの製造方法 |
-
2015
- 2015-10-28 JP JP2015211413A patent/JP6485914B2/ja active Active
-
2016
- 2016-10-17 EP EP16782221.2A patent/EP3368518B1/en active Active
- 2016-10-17 MX MX2018005046A patent/MX2018005046A/es active IP Right Grant
- 2016-10-17 AU AU2016344537A patent/AU2016344537B2/en active Active
- 2016-10-17 US US15/764,309 patent/US10472338B2/en active Active
- 2016-10-17 ES ES16782221T patent/ES2766474T3/es active Active
- 2016-10-17 CN CN201680062917.1A patent/CN108137520B/zh active Active
- 2016-10-17 CA CA2998985A patent/CA2998985C/en active Active
- 2016-10-17 RU RU2018113741A patent/RU2733398C2/ru active
- 2016-10-17 WO PCT/EP2016/074840 patent/WO2017071980A1/en active Application Filing
-
2018
- 2018-03-15 IL IL258148A patent/IL258148B/en active IP Right Grant
- 2018-07-06 HK HK18108745.1A patent/HK1249098A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MX2018005046A (es) | 2018-06-13 |
US10472338B2 (en) | 2019-11-12 |
CN108137520B (zh) | 2022-06-21 |
JP2017081847A (ja) | 2017-05-18 |
EP3368518B1 (en) | 2019-12-04 |
RU2018113741A3 (zh) | 2020-02-20 |
US20190055207A1 (en) | 2019-02-21 |
IL258148B (en) | 2020-08-31 |
CN108137520A (zh) | 2018-06-08 |
AU2016344537A1 (en) | 2018-04-12 |
EP3368518A1 (en) | 2018-09-05 |
RU2018113741A (ru) | 2019-11-28 |
AU2016344537B2 (en) | 2020-09-17 |
RU2733398C2 (ru) | 2020-10-01 |
CA2998985C (en) | 2023-10-31 |
IL258148A (en) | 2018-05-31 |
KR20180073581A (ko) | 2018-07-02 |
WO2017071980A1 (en) | 2017-05-04 |
ES2766474T3 (es) | 2020-06-12 |
BR112018007545A2 (pt) | 2018-10-23 |
CA2998985A1 (en) | 2017-05-04 |
JP6485914B2 (ja) | 2019-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201603903QA (en) | Wafer producing method | |
SG10201603714RA (en) | Wafer producing method | |
SG10201605092PA (en) | Wafer producing method | |
SG10201604080XA (en) | Wafer producing method | |
SG10201600555UA (en) | Wafer producing method | |
SG10201600557XA (en) | Wafer producing method | |
SG10201510273SA (en) | Wafer producing method | |
SG10201600552YA (en) | Wafer producing method | |
SG10201510271QA (en) | Wafer producing method | |
SG10201601981YA (en) | Wafer producing method | |
SG10201601975SA (en) | Wafer producing method | |
PT3352896T (pt) | Método de produção de isocianatos | |
EP3333266A4 (en) | PROCESS FOR THE PRODUCTION OF SELENOEINE | |
SG11201701863VA (en) | Method for producing methionine | |
PL3227023T3 (pl) | Sposób wytwarzania kropel | |
IL266044B (en) | Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides | |
EP3666729C0 (en) | PROCESS FOR THE PRODUCTION OF NANO-SULFUR | |
EP3296282A4 (en) | METHOD FOR PRODUCING HYDROHALOGEN FLUOROLEFINES | |
IL252173A0 (en) | Methods for the production of methyl dichlorophosphane | |
GB201500427D0 (en) | Method | |
EP3275886A4 (en) | Method for producing dialkylaminosilane | |
EP3265120C0 (en) | PROCEDURE | |
SG11201701326YA (en) | Method for producing oligosilane | |
HK1249098A1 (zh) | 用於生產氟美他酚的方法 | |
GB201501565D0 (en) | Method |